Carbon Ion Irradiation Activates Anti-Cancer Immunity

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Mar 13

PMID 38474078

Authors

Makoto Sudo

Hiroko Tsutsui

Jiro Fujimoto

Affiliations

Soon will be listed here.

Abstract

Carbon ion beams have the unique property of higher linear energy transfer, which causes clustered damage of DNA, impacting the cell repair system. This sometimes triggers apoptosis and the release in the cytoplasm of damaged DNA, leading to type I interferon (IFN) secretion via the activation of the cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Dendritic cells phagocytize dead cancer cells and damaged DNA derived from injured cancer cells, which together activate dendritic cells to present cancer-derived antigens to antigen-specific T cells in the lymph nodes. Thus, carbon ion radiation therapy (CIRT) activates anti-cancer immunity. However, cancer is protected by the tumor microenvironment (TME), which consists of pro-cancerous immune cells, such as regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. The TME is too robust to be destroyed by the CIRT-mediated anti-cancer immunity. Various modalities targeting regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages have been developed. Preclinical studies have shown that CIRT-mediated anti-cancer immunity exerts its effects in the presence of these modalities. In this review article, we provide an overview of CIRT-mediated anti-cancer immunity, with a particular focus on recently identified means of targeting the TME.

References

Wang D, Sun H, Wei J, Cen B, DuBois R . CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017; 77(13):3655-3665. PMC: 5877403. DOI: 10.1158/0008-5472.CAN-16-3199. View

Cai H, Li L, Slavik K, Huang J, Yin T, Ai X . The virus-induced cyclic dinucleotide 2'3'-c-di-GMP mediates STING-dependent antiviral immunity in Drosophila. Immunity. 2023; 56(9):1991-2005.e9. PMC: 11781366. DOI: 10.1016/j.immuni.2023.08.006. View

Multhoff G, Pockley A, Schmid T, Schilling D . The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation. Cancer Lett. 2015; 368(2):179-84. DOI: 10.1016/j.canlet.2015.02.013. View

Girardi M, Oppenheim D, Steele C, Lewis J, Glusac E, Filler R . Regulation of cutaneous malignancy by gammadelta T cells. Science. 2001; 294(5542):605-9. DOI: 10.1126/science.1063916. View

Street S, Cretney E, Smyth M . Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 2001; 97(1):192-7. DOI: 10.1182/blood.v97.1.192. View

McLaughlin M, Patin E, Pedersen M, Wilkins A, Dillon M, Melcher A . Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer. 2020; 20(4):203-217. DOI: 10.1038/s41568-020-0246-1. View

Rayes R, Mouhanna J, Nicolau I, Bourdeau F, Giannias B, Rousseau S . Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. JCI Insight. 2019; 5. PMC: 6777835. DOI: 10.1172/jci.insight.128008. View

Tinganelli W, Durante M . Carbon Ion Radiobiology. Cancers (Basel). 2020; 12(10). PMC: 7603235. DOI: 10.3390/cancers12103022. View

Wculek S, Cueto F, Mujal A, Melero I, Krummel M, Sancho D . Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2019; 20(1):7-24. DOI: 10.1038/s41577-019-0210-z. View

10.

Gao J, Liang Y, Wang L . Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. Front Immunol. 2022; 13:888713. PMC: 9280632. DOI: 10.3389/fimmu.2022.888713. View

11.

Rodriguez-Ruiz M, Rodriguez I, Leaman O, Lopez-Campos F, Montero A, Conde A . Immune mechanisms mediating abscopal effects in radioimmunotherapy. Pharmacol Ther. 2018; 196:195-203. DOI: 10.1016/j.pharmthera.2018.12.002. View

12.

Antonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R . Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 377(20):1919-1929. DOI: 10.1056/NEJMoa1709937. View

13.

Arico E, Castiello L, Capone I, Gabriele L, Belardelli F . Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications. Cancers (Basel). 2019; 11(12). PMC: 6966569. DOI: 10.3390/cancers11121943. View

14.

Seubert B, Grunwald B, Kobuch J, Cui H, Schelter F, Schaten S . Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology. 2014; 61(1):238-48. PMC: 4280301. DOI: 10.1002/hep.27378. View

15.

Kaplan D, Shankaran V, Dighe A, STOCKERT E, Aguet M, Old L . Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998; 95(13):7556-61. PMC: 22681. DOI: 10.1073/pnas.95.13.7556. View

16.

Huang Q, Hu J, Chen L, Lin W, Yang J, Hu W . Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosis. Cancer Immunol Immunother. 2023; 72(12):4077-4088. PMC: 10700413. DOI: 10.1007/s00262-023-03544-x. View

17.

Chen J, Pan Q, Bai Y, Chen X, Zhou Y . Hydroxychloroquine Induces Apoptosis in Cholangiocarcinoma Reactive Oxygen Species Accumulation Induced by Autophagy Inhibition. Front Mol Biosci. 2021; 8:720370. PMC: 8462510. DOI: 10.3389/fmolb.2021.720370. View

18.

van Vlerken-Ysla L, Tyurina Y, Kagan V, Gabrilovich D . Functional states of myeloid cells in cancer. Cancer Cell. 2023; 41(3):490-504. PMC: 10023509. DOI: 10.1016/j.ccell.2023.02.009. View

19.

Cavalieri S, Vitolo V, Barcellini A, Ronchi S, Facoetti A, Campo C . Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC). Future Oncol. 2023; 19(3):193-203. DOI: 10.2217/fon-2022-0503. View

20.

Zhou H, Yang P, Li H, Zhang L, Li J, Zhang T . Carbon ion radiotherapy boosts anti-tumour immune responses by inhibiting myeloid-derived suppressor cells in melanoma-bearing mice. Cell Death Discov. 2021; 7(1):332. PMC: 8566527. DOI: 10.1038/s41420-021-00731-6. View